Avalo Therapeutics Stock Price on August 14, 2024
| AVTX Stock | USD 10.13 0.48 4.97% |
Below is the normalized historical share price chart for Avalo Therapeutics extending back to November 13, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Avalo Therapeutics stands at 10.13, as last reported on the 24th of November, with the highest price reaching 10.51 and the lowest price hitting 9.40 during the day.
If you're considering investing in Avalo Stock, it is important to understand the factors that can impact its price. Avalo Therapeutics appears to be risky, given 3 months investment horizon. Avalo Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0357, which signifies that the company had a 0.0357% return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Avalo Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Avalo Therapeutics' mean deviation of 4.88, and Risk Adjusted Performance of 0.0663 to double-check if our risk estimates are consistent with your expectations.
At this time, Avalo Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 291.6 K in 2024, whereas Common Stock is likely to drop 950.00 in 2024. . Price To Sales Ratio is likely to drop to 1.25 in 2024. Price Earnings Ratio is likely to drop to -0.08 in 2024. Avalo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of November 2015 | 200 Day MA 10.5021 | 50 Day MA 11.059 | Beta 1.034 |
Avalo |
Sharpe Ratio = 0.0357
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AVTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.48 actual daily | 57 57% of assets are less volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 2 98% of assets perform better |
Based on monthly moving average Avalo Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avalo Therapeutics by adding it to a well-diversified portfolio.
Price Book 5.0293 | Enterprise Value Ebitda (0.19) | Price Sales 129.2638 | Shares Float 5.1 M | Wall Street Target Price 35 |
Related Headline
Alx Oncology Headline on 14th of August 2024
Disposition of 2191 shares by Jason Lettmann of Alx Oncology... by MacroaxisInsider
Filed transaction by Alx Oncology Holdings Director, Officer: Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Avalo Therapeutics Valuation on August 14, 2024
It is possible to determine the worth of Avalo Therapeutics on a given historical date. On August 14, 2024 Avalo was worth 9.61 at the beginning of the trading date compared to the closed value of 10.17. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Avalo Therapeutics stock. Still, in general, we apply an absolute valuation method to find Avalo Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Avalo Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Avalo Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 10.47 | 10.50 | 9.65 | 9.88 | 9,761 | |
08/14/2024 | 9.61 | 10.46 | 9.61 | 10.17 | 8,373 |
| 9.36 | 9.75 | 9.25 | 9.30 | 11,569 |
| Backtest Avalo Therapeutics | | | Avalo Therapeutics History | | | Avalo Therapeutics Valuation | Previous | Next |
Avalo Therapeutics Trading Date Momentum on August 14, 2024
| On August 15 2024 Avalo Therapeutics was traded for 9.30 at the closing time. The top price for the day was 9.75 and the lowest listed price was 9.25 . The trading volume for the day was 11.6 K. The trading history from August 15, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 8.55% . The overall trading delta against the current closing price is 0.69% . |
Avalo Therapeutics Fundamentals Correlations and Trends
By evaluating Avalo Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Avalo Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Avalo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Avalo Therapeutics Stock history
Avalo Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Avalo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Avalo Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Avalo Therapeutics stock prices may prove useful in developing a viable investing in Avalo Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 277.7 K | 291.6 K | |
| Net Loss | -75.9 M | -72.1 M |
Avalo Therapeutics Stock Technical Analysis
Avalo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Avalo Therapeutics Period Price Range
Low | November 24, 2024
| High |
0.00 | 0.00 |
Avalo Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Avalo Therapeutics November 24, 2024 Market Strength
Market strength indicators help investors to evaluate how Avalo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Avalo Therapeutics shares will generate the highest return on investment. By undertsting and applying Avalo Therapeutics stock market strength indicators, traders can identify Avalo Therapeutics entry and exit signals to maximize returns
Avalo Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Avalo Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Avalo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Avalo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0663 | |||
| Jensen Alpha | 0.5325 | |||
| Total Risk Alpha | (0.55) | |||
| Sortino Ratio | 0.0544 | |||
| Treynor Ratio | (1.20) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Avalo Stock Analysis
When running Avalo Therapeutics' price analysis, check to measure Avalo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avalo Therapeutics is operating at the current time. Most of Avalo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Avalo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avalo Therapeutics' price. Additionally, you may evaluate how the addition of Avalo Therapeutics to your portfolios can decrease your overall portfolio volatility.